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Summary
Herein we report the expanded functional group com-
patibility of small-molecule microarrays to include im-
mobilization of primary alcohols, secondary alcohols,
phenols, carboxylic acids, hydroxamic acids, thiols,
and amines on a single slide surface. Small-molecule
‘‘diversity microarrays’’ containing nearly 10,000
known bioactive small molecules, natural products,
and small molecules originating from several diver-
sity-oriented syntheses were produced by using an
isocyanate-mediated covalent capture strategy. Se-
lected printed bioactive compounds were detected
with antibodies against compounds of interest. The
new surface of the diversity microarrays is highly com-
patible with approaches involving cellular lysates.
This feature has enabled a robust, optimized screen-
ing methodology using cellular lysates, allowing the
detection of specific interactions with a broad range
of binding affinity by using epitope-tagged or chimeric
fluorescent proteins without prior purification. We be-
lieve that this expanded research capability has con-
siderable promise in biology and medicine.
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Natural products and products of diversity-oriented
synthesis (DOS) constitute a rich pool of small mole-
cules from which specific ligands to proteins of interest
may be found [1]. Small-molecule microarrays [2–11]
(SMMs) enable the discovery of previously unknown
protein-ligand interactions, resulting in small-molecule
modulators of protein function [12, 13]. To make
SMMs, stock solutions of compounds are robotically ar-
rayed onto functionalized glass microscope slides that
are incubated with proteins of interest. Microarray fea-
tures representing putative interactions between pro-
teins and small molecules are typically visualized with
fluorescently labeled antibodies and a standard fluores-
cence slide scanner.
Several mild and selective coupling reactions have
been used to capture covalently synthetic compounds
onto glass surfaces and include a Michael addition
[10], addition of a primary alcohol to a silyl chloride [4],
diazobenzylidene-mediated capture of phenols [2],
1,3-dipolar cycloaddition [3], a Diels-Alder reaction [5],
a Staudinger ligation of azides onto phosphane-modi-
fied slides [7], and capture of hydrazide-linked com-
pounds onto epoxide-functionalized glass and vice
versa [8, 9]. Most of these surface capture methods
take advantage of a reactive functional group that is in-
troduced as part of a solid-phase organic synthesis and
biases the orientation of the small molecule on the sur-
face [7, 14]. Nonselective photoinduced crosslinking
has also been used to immobilize a set of ten complex
natural products onto glass slides [6]. Noncovalent ap-
proaches have also been employed, such as the hybrid-
ization of peptide-nucleic acid conjugates to oligonucle-
otide arrays [15, 16].
Using selective approaches, our laboratories have im-
mobilized over 50,000 products of diversity-oriented
synthesis pathways via capture through a primary or
secondary alcohol on chlorinated slides or through cap-
ture of phenols on diazobenzylidene-functionalized
slides [2, 4, 12]. Unfortunately, the previous approaches
forced us to make separate microarrays for compounds
that contained either a primary or secondary alcohol
and compounds containing aryl alcohols. We hoped to
develop arrays that would capture all three types of
alcohols on a common slide surface. Additionally, we
hoped to include compounds from natural sources, not
necessarily bearing primary alcohols, secondary alco-
hols, or phenols, alongside synthetic compounds in the
microarrays. We turned to nonselective photoinduced
crosslinking as a capture method and experienced
mixed results. Although we successfully printed and
detected several of the known ligands described by
Kanoh et al. [6], our attempts to print and screen micro-
arrays of 6336 phenol-containing fused bicycles and
tetracycles [2, 17] provided unacceptable numbers of
false positives as judged by secondary binding assays
using surface plasmon resonance. This experience
led us to pursue new capture strategies that would
allow immobilization of several common functional
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494Figure 1. Schematic Design of the Diversity SMM Containing Bioactive Small Molecules and Products of Diversity-Oriented Synthesis
Reactive functional groups are colored. Representative bioactive small molecules printed in the diversity array include 1a, nigericin; 1b, ba-
filomycin A1; 1c, doxorubicin; 1d, genistein; 1e, lactacystin; 1f, uvaol; 1g, D-erythro-sphingosine; 1h, gibberellic acid; 1i, ingenol; 1j, aloin. Rep-
resentative scaffolds for DOS small molecules printed in the diversity array include 2a, dihydropyrancarboxamides [23]; 2b, alkylidene-pyran-
3-ones [18, 19]; 2c, fused pyrrolidines [20]; 2d, serine-derived peptidomimetics; 2e, shikimic acid-derived compounds; 2f, 1,3-dioxanes [24];
2g, spirooxindoles [22]; 2h, macrocyclic lactones; 2i, ansa-seco steroid-derived compounds [21].groups that are present in both synthetic and natural
compounds.
We have previously reported the use of SMMs to dis-
cover ligands for calmodulin (calmoduphilins) [2], the
yeast transcriptional corepressor Ure2p (uretupamines)
[13], and the Hap3p subunit of the yeast HAP transcrip-
tion factor complex (haptamides) [12]. Each of these
screens involved SMMs in which only one DOS library
was contained on a given slide. More recently, we
sought to prepare an SMM that contains sublibraries
from various DOS synthetic routes in one array. The
goal of preparing such an SMM is to allow researchers
to sample the various sublibraries in one array and
then prioritize screens of the full DOS libraries based
on the initial screening results from the diverse subset.
Here we report the use of isocyanate-functionalized
glass slides to make a small-molecule ‘‘diversity micro-
array’’ containing several collections of DOS com-
pounds coming from various solid-phase organic syn-
thesis routes [18–24] and commercially available
bioactive compounds, including natural products, on
the same slide (Figure 1). Isocyanates react with a num-
ber of nucleophilic functional groups without leaving an
acidic byproduct [25] and an isocyanate surface thereby
increases the diversity of small molecules, from natural
or synthetic sources, that can be immobilized onto a sin-gle SMM. Isocyanate glass substrates have also been
prepared and used to immobilize oligonucleotides in
a microarray format [26–29].
Prior strategies aimed at ligand discovery using
SMMs have relied on incubation with a purified protein
of interest. Potential applications of these protocols
have been limited by challenges in protein biochemistry
involving expression of large proteins, solubility, post-
translational modification state, activity, and yield. Fur-
thermore, without commercial availability of a protein
target of interest, investigators without expertise in pro-
tein biochemistry may be limited in their capacity to
screen SMMs. Here we describe the optimization of a ro-
bust, efficient SMM screening methodology which al-
lows the detection of specific protein-small molecule in-
teractions by using epitope-tagged target proteins
directly from cell lysates without purification. We dem-
onstrate that the new attachment chemistry is compati-
ble with detection of known interactions between vari-
ous small molecules and FKBP12 [30, 31] obtained
directly from cellular lysates. Previous research report-
ing the detection of specific interactions with complex
lysates has typically involved the addition of known,
purified proteins [32] or has required incubation in solu-
tion with focused libraries of covalent probes conju-
gated to nucleic acids prior to spatial arraying on an
Small-Molecule Microarrays and Cellular Lysates
495Figure 2. Vapor-Catalyzed Surface Immobilization Scheme
g-aminopropylsilane (GAPS) slides (S1) are coated with a short Fmoc-protected polyethylene glycol spacer. After removal of the Fmoc group
with piperidine, 1,6-diisocyanatohexane is coupled to the surface via urea bond formation to generate putative isocyanate-functionalized glass
slides (S2). Slides printed with compound stock solutions are then placed in a dry environment and exposed to a pyridine vapor that catalyzes
the covalent capture of small molecules onto the slide surface (S3).oligonucleotide array [15, 16]. The ability to detect se-
lective interactions in cellular lysates without protein
purification is appealing for ligand discovery, target
identification, antibody and protein specificity profiling,
as well as for future applications such as signature
discovery for cellular states and diagnostic tool
development.
Results
Small molecules containing nucleophiles with a range of
reactivities were arrayed onto a weakly electrophilic sur-
face that reacts slowly with either the small molecules or
ambient moisture and yields no potentially deleterious
byproducts such as an acid. As shown in Figure 2, g-
aminopropylsilane slides (S1) were coated with a short
polyethylene glycol (PEG) spacer and coupled to 1,6-dii-
socyanatohexane via a urea bond to generate putative
isocyanate-functionalized glass slides (S2). Slides
printed with compound stock solutions were then
placed in a dry environment and exposed to a pyridine
vapor that catalyzes the covalent capture of small mole-
cules onto the slide surface (S3).
To evaluate this approach, a robotic microarrayer was
used to print a series of synthetic FKBP12 ligands [33]
that were derivatized so as to present a primary alcohol
(3a, 3o, 3p, 3q), secondary alcohol (3b), tertiary alcohol
(3c), phenol (3d), methyl ether (3e), carboxylic acid (3f),
hydroxamic acid (3g), methyl (3h), thiol (3i), primary
amine (3j, 3n), secondary amine (3k), indole (3l), or aryl
amine (3m) onto the isocyanate-derivatized slides (Fig-
ures 3A and 3B). The site of modification for each
FKBP12 ligand has previously been shown to be tolerant
to substitution as 3 is a parent structure for chemical in-
ducers of dimerization [34]. The ligands were printed in
serial 2-fold dilutions (10 mM to 20 mM) with DMF as
a solvent. The printed slides were exposed to pyridine
vapor, quenched with ethylene glycol, and washed ex-
tensively with DMF, THF, and methanol. Dried slides
were probed with FKBP12-GST [30, 31], followed by
a Cy5-labeled anti-GST antibody, and scanned for fluo-
rescence at 635 nm with GenePix Pro 6.0 software (Mo-lecular Devices, Union City, CA). As shown in Figure 3,
the intensity of fluorescent signals corresponding to
FKBP12-GST varied according to both the functional
group presented for attachment and concentration of li-
gand. Feature diameter was dependent on the concen-
tration of ligand, and at higher concentrations the aver-
age diameter was 250 mm. The primary amines, aryl
amine, and thiol appear to have the highest immobiliza-
tion levels. Fluorescence intensities for the primary alco-
hols, phenol, hydroxamic acid, secondary amine, and in-
dole are also consistent with significant immobilization.
The secondary alcohol, carboxylic acid, and tertiary al-
cohol were immobilized in lower amounts. At 1.25 mM,
a typical concentration for our compound stock solu-
tions, trace levels of primary amides 3e and 3h were de-
tected whereas theN,N-substituted amide 3r (Figure 3D)
was not. The addition of polyethylene glycol spacers of
varying lengths to the ligand (3n–3q) did not make a sig-
nificant impact on the feature morphology or fluores-
cence intensity when probed with purified protein. Addi-
tionally, polyethylene glycol spacers of varying lengths
(n = 0, 2, 4, 8, 70) were added to surface S2 and com-
pared (data not shown). Surfaces with shorter PEG
chains (n = 2, 4, 8) were equivalent and displayed im-
proved signal-to-noise ratios over the surface without
PEG. The surface with longer PEG chains displayed
the lowest fluorescence levels in the binding assay and
gave inconsistent spot morphologies.
Fluorescence levels were significantly reduced when
pyridine vapor was omitted from the procedure (Fig-
ure 3D). Immobilization levels were slightly enhanced
when the slides were exposed to pyridine at 37ºC
(data not shown). To test the sensitivity of this capture
method to moisture present in the compound stock so-
lutions used for printing, 1 mM solutions of FKBP12 li-
gands 3a, 3b, 3c, and 3e in 9:1 DMF:ddH2O were arrayed
in triplicate onto isocyanate-derivatized slides (Fig-
ure 3E). Fluorescence intensities were equivalent to
those of compounds printed directly from DMF. Toler-
ance to water is an important consideration for SMM
preparation because compound stock solutions in DMF
and DMSO appear to take on water over time as they
Chemistry & Biology
496Figure 3. Comparison of Functional Group Reactivity with Isocyanate-Functionalized Glass
(A) Parent structure of AP1497 derivatives 3a–3q.
(B) AP1497 derivative array with FKBP12 ligands 3a–3q printed in serial 2-fold dilutions (10 mM to 20 mM) onto isocyanate-derivatized slides.
The slides were exposed to pyridine vapor to catalyze the attachment of printed compounds. Washed slides were probed with FKBP12-GST
followed by a Cy5-labeled anti-GST antibody. An image for a microarray scanned for fluorescence at 635 nm is shown. The functional groups
presented for surface capture are shown at the top of the array.
(C) Total fluorescence intensity was computed within 300 mm spots centered on each microarray feature with GenePix Pro 6.0 microarray anal-
ysis software. The capture of small molecules is catalyzed in the presence of pyridine vapor and is tolerant of moisture in compound stock
solutions.
(D) Solutions of FKBP12 ligands 3a, 3d, 3e, 3r, and 3s (1 mM) in DMF were arrayed in triplicate onto surface S2 and the slides were incubated
either under an atmosphere of N2 (bottom) or in the presence of pyridine vapor under an atmosphere of N2 (top).
(E) Solutions of FKBP12 ligands 3a, 3d, 3h, and 3s (1 mM) in DMF (top row) or 9:1 DMF:ddH2O (bottom row) were arrayed in triplicate onto
isocyanate-derivatized slides.
Small-Molecule Microarrays and Cellular Lysates
497move in and out of freezer storage [35]. Small molecules
printed from DMSO were also captured by using this
method with smaller feature diameters (w100–150 mm)
than compounds printed from DMF (w250–300 mm)
(data not shown).
To investigate the suitability of our approach for print-
ing compounds that have not been intentionally synthe-
sized with appendages for covalent capture, more than
300 commercially available bioactive compounds were
printed onto isocyanate-functionalized slides. We
screened these bioactive microarrays with rabbit pri-
mary antibodies against corticosterone, digitoxin, and
17b-estradiol, followed by a fluor-labeled goat anti-rab-
bit secondary antibody. The signal-to-noise ratio (SNR)
was determined by calculating intensity at 635 nm and
adjusting for local background for each feature on repli-
cate arrays, and data were compared to replicate con-
trol arrays incubated with the labeled secondary anti-
body alone (Figure 4). Six bioactives, with SNR ratios
>3.0, were found in replicate arrays to bind to the labeled
polyclonal secondary antibody alone. None of the com-
pounds were autofluorescent at 635 nm as judged by ar-
rays probed with PBS buffer alone (data not shown). Hy-
gromycin B, an aminoglycoside antibiotic, gave the
highest adjusted SNR (mean 47.6). Three quinolone an-
tibiotics, norfloxacin, ciprofloxacin, and pipemidic acid,
displayed mean adjusted fluorescent intensities greater
than 3.0 in at least one experiment. In the anti-cortico-
sterone antibody binding profile, hydrocortisone (mean
SNR 68.9), beclomethasone (63.3), and corticosterone
(59.2), corticosteroids related in structure, scored as
positives. Gitoxigenin (mean SNR 62.5), convallatoxin
(52.7), lanatoside C (24.0), digoxin (17.8), and digitoxin
(15.1), all cardioactive steroid glycosides, likewise
scored as positives in replicate anti-digitoxin antibody
experiments. 17b-estradiol (mean SNR 9.0), estriol
(8.7), and estrone (7.3), primary estrogenic hormones
varying in the number of reactive groups for capture,
scored as positives in the anti-17b-estradiol binding
profile. The antibody binding profiles demonstrate that
small molecules with multiple nucleophilic functional
groups can be printed and detected by using isocya-
nate-mediated capture. Additionally, these data demon-
strate a facile approach for profiling the specificity of im-
munoglobulins for small molecules.
We aimed to expand the scope of this method to in-
clude the detection of interactions between small mole-
cules and target proteins expressed in mammalian cells
without prior purification. Toward this end, a screening
protocol was developed whereby SMMs incubated
with cellular lysates bearing overexpressed epitope-
tagged proteins of interest are compared with control
SMMs incubated with mock-transfected cellular lysates
(Figure 5A). First attempts at this approach were unsuc-
cessful due to an unfavorable interaction between the
slide surface and cellular lysates prepared from a phos-
phate-buffered RIPA lysis buffer, yielding a uniform,
high fluorescent background. By varying buffer condi-
tions, we identified optimal signal-to-noise ratios by us-
ing an MIPP lysis buffer. These initial experiments high-
light the importance of nonfluorescent detergents and
buffer ionic strength, such that a balance between effi-
cient cellular lysis and nonspecific surface interactions
is achieved. Following lysis and clarification by centrifu-gation, cellular lysates were incubated on SMMs. Sub-
sequently, the arrays were serially incubated with a pri-
mary anti-epitope antibody and a Cy5-conjugated
secondary antibody. A brief wash with PBST and mild
agitation followed each incubation. Fluorescence inten-
sity was detected and SNR was calculated, compared,
and averaged for corresponding features on replicate
arrays.
We explored this approach by screening the array of
AP1497 derivatives (as in Figure 3B) against HEK-293T
lysates prepared from mammalian cells transiently
transfected with a construct expressing FLAG-
FKBP12. Optimization experiments were undertaken
with a stepwise introduction of variation to identify pa-
rameters maximizing protocol robustness. Arrays were
derived from the same printing series and were scanned
for fluorescence by using identical laser power and pho-
tomultiplier tube gain. Experimental variables were
compared by using mean SNR for ligands arrayed at
a uniform, standard concentration of 1.25 mM, as de-
picted in Figure 5B. To determine whether the total pro-
tein concentration affects ligand detection, SMMs were
incubated with lysates varying in concentration from 0.1
to 1.0 mg/ml. Maximum fluorescence intensity and SNR
for each feature proved optimal at 0.3 mg/ml. Blocking in-
cubations are commonly employed in protocols involv-
ing SMMs. Given the complex milieu of cellular lysates,
we were interested in exploring whether blocking prior
to sample incubation is required. Blocking with BSA
was found to diminish both the maximum signal inten-
sity and SNR when incubating SMMs with cellular ly-
sates. Interactions between printed ligands and macro-
molecules may be enhanced with the introduction of
a polymeric polyethylene glycol (PEG) spacer, which ad-
ditionally may minimize nonspecific protein adsorption.
To investigate the effect of spacer length on fluorescent
detection and SNR, PEG spacer length was varied in
printed AP1497 derivative SMMs. A marked decrease
in the SNR was observed for each printed feature with
a long (nw 70) PEG spacer compared to a substantially
shorter spacer (n = 2). Additional optimization experi-
ments and the detailed, optimized screening protocol
for SMMs with cellular lysates are presented in Supple-
mental Data available with this article online.
Recognizing the high affinity of AP1497 for FKBP12
(KD = 8.8 nM), we were interested in assessing the ability
of this technique to identify lower affinity interactions as
may be detected in screening experiments. Focused ar-
rays of two ligands with disparate affinity for FKBP12
(Figure 6A) were printed with control bioactives. The op-
timized screening protocol allowed the specific identifi-
cation of ligands with KD as a high as 2.6 mM (Figure 6B)
[36]. To determine whether this method would allow the
detection of low-affinity interactions between small mol-
ecules and chimeric fluorescent proteins, SMMs were
incubated with lysates from mammalian cells transiently
transfected with a vector encoding an EGFP-FKBP12 fu-
sion protein. Incubated slides were washed briefly with
PBST and scanned for fluorescence at 488 nm. Identifi-
cation of ligands with low binding affinity was observed
without the requirement of primary and fluorescently la-
beled secondary antibodies (Figure 6C). Transient trans-
fection of cells in tissue culture with protein expression
constructs typically results in protein overexpression,
Chemistry & Biology
498Figure 4. Detection of Selected Printed Bioactives with Antibodies
Fluorescence intensity relative to background signal for each printed bioactive is shown for binding profiles of (A) anti-corticosterone, (B) anti-
digitoxin, and (C) anti-estradiol (rabbit) antibodies followed by Alexa Fluor 647 goat anti-rabbit, relative to (D) an Alexa Fluor 647 goat anti-rabbit
IgG (A647 Rabbit) control. The signal-to-noise ratio at 635 nm (SNR635) is defined by (mean foreground2mean background)/(standard deviation
of background). Data represent mean values of duplicate spots on an individual array confirmed by two independent experiments. All com-
pounds with SNR635 values greater than 3.0 are labeled. Fluorescence intensity data sets for each profile are available in Supplemental Data.
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499as in the experiments above. In the context of ligand
discovery, this may prove desirable; however, addi-
tional applications of SMMs such as profiling of cellular
states require the detection of specific interactions
with endogenously expressed proteins by using target
Figure 5. Screening Small-Molecule Microarrays with Cellular
Lysates
(A) Schematic of the methodology. An epitope-tagged expression
construct bearing a target protein of interest is introduced into
a mammalian cell line by transient transfection. After 48 hr,
replicate small-molecule microarrays are incubated serially with
clarified lysate, primary anti-epitope antibody, and finally a fluoro-
phore-labeled secondary antibody. A gentle, brief wash is per-
formed in PBS following each incubation. Fluorescence intensity
is computed with GenePix Pro 6.0 microarray analysis software,
and intensity relative to background signal (SNR635) for each
printed small molecule is compared to replicate control arrays in-
cubated with a cellular lysate from a mock-transfected, identical
cell line.
(B) Optimization of lysate screening methodology. Flag-FKBP12
overexpressed in HEK-293T cells and appropriate antibodies
were selected for screening optimization experiments performed
as depicted in (A) with FKBP12-ligand arrays patterned as identical
triplicate subarrays with 2-fold dilutions (10 mM to 20 mM) as de-
scribed in Figure 3B. Protocol conditions were serially optimized
in a stepwise fashion. Data presented represent mean values
(SNR635) of spots from triplicate subarrays. Data corresponding
to FKBP12 derivatives 3a–3q (red) are compared to reference,
blank DMF spots (black) for experiments testing total protein con-
centration, the effects of blocking with bovine serum albumin
(BSA), and polyethylene glycol (PEG) linker length. Complete opti-
mization data are available in Supplemental Data.protein-specific antibodies. To explore this possibility,
SMMs were incubated with lysates from untransfected
293T cells. Subsequent incubation with a commercially
available polyclonal antibody against the N-terminal re-
gion of FKBP12 and secondary fluorophore-conjugated
antibody allowed the detection of specific interactions
between endogenous FKBP12 and ligands with KD as
high as 2.6 mM (Figure 6D).
To investigate the robustness of our optimized lysate
protocol as a screening methodology, a diverse SMM
was printed containing 10,000 bioactive small mole-
cules, natural products, and small molecules originating
from diversity-oriented syntheses. The microarray also
included 27 features corresponding to synthetic ligands
to FKBP12 (3–5), and the immunosuppressant natural
product rapamycin, a known ligand to FKBP12. Ten cel-
lular lysates (five control and five Flag-FKBP12) were in-
dependently prepared and incubated with a diversity
SMM. After incubation with primary and Cy5-labeled
secondary antibodies, slides were scanned for fluores-
cence at 635 nm and feature SNR was calculated.
Among five replicate SMMs with Flag-FKBP12-express-
ing lysate, all 27 printed ligands to FKBP12, including ra-
pamycin and the low-affinity synthetic ligand 5, were de-
tected. A representative array is presented in Figure 7A.
To interrogate statistically the ability of our technique
to identify ligands to a protein of interest on a diverse ar-
ray, locally corrected feature intensity (SNR635) was di-
chotomized by a threshold intensity of 2.24, established
by the maximal SNR intensity of arrayed solvent. Fea-
tures with SNR intensities greater than 2.24 were classi-
fied as positives. Features from control- or Flag-
FKBP12-incubated arrays were compared by using
Fisher’s exact test, and contingency tables were gener-
ated for 104 solvent-only features that appeared as hits
in at least one experiment. At a significance level of 0.05,
24 cells were found to have a significant p value (Fig-
ure 7B). One DOS compound, 1276-M08, also scored
as an assay positive. Binding was confirmed by surface
plasmon resonance; however, the resynthesized, major
product from the well was found to bind both GST and
GST-FKBP12 by surface plasmon resonance, indicating
that the molecule is likely not a selective ligand for
FKBP12.
Discussion
We used a covalent capture strategy for small molecules
that makes use of a well-characterized chemical reac-
tion [25–29] and allows preparation for the first time of
microarrays containing small molecules coming from
both natural and synthetic sources. The isocyanate-me-
diated capture is applicable to compounds containing
a variety of nucleophilic functional groups and does
not require compounds to contain a special reactive ap-
pendage, such as an alcohol or azide [2, 4, 7], to be intro-
duced during synthesis for covalent capture in the array.
The isocyanate functionality generates no byproducts,
in contrast to previous capture agents developed in
our lab, including those using electropositive chlorine
moieties [4]. The latter resulted in the deposition and
concentration of an acidic residue in the vicinity of the
small molecule, which could result in partial degradation
of the small molecule and obfuscation of the screening
Chemistry & Biology
500Figure 6. Detection of Binding to Ligands of
Varying Affinity by Using Cellular Lysates
(A) Derivatives of AP1497 with varying affini-
ties for FKBP12 (27, 28) were obtained and
printed in quadruplicate with control com-
pounds captopril and glutathione.
(B) Arrays were incubated with clarified ly-
sates of HEK-293T cells overexpressing
Flag-FKBP12 and appropriate antibodies as
depicted in Figure 5A. A false-colored, repre-
sentative image of an array scanned for fluo-
rescence at 635 nm is shown.
(C) Arrays were incubated with clarified ly-
sates of HEK-293T cells overexpressing
EGFP-FKBP12. A false-colored, demonstra-
tive image of an array scanned for fluores-
cence at 488 nm is shown.
(D) Arrays were incubated with clarified ly-
sates of untransfected HEK-293T cells and
probed with a polyclonal antibody against
FKBP12. A false-colored, representative im-
age of an array scanned for fluorescence at
635 nm is shown.results. Compounds containing multiple nucleophilic
functional groups also have the potential to be displayed
in varying orientations in a given spot. Multiple modes of
display may allow proteins to sample different binding
orientations in a given microarray feature. The isocya-
nate slides may, however, react with a nucleophile that
is required for protein binding and may therefore lead
to false negatives in screens. Due to this potential het-
erogeneity within printed features, we pursued surface
plasmon resonance-based secondary binding assays
to prioritize positives for follow-up. This approach al-
lows us to identify rapidly candidate ligands by using
the high-throughput microarray screening platform
and the surface plasmon resonance platform quantita-
tively to characterize positives in real time.
The capture method has allowed us to produce micro-
arrays that contain compounds derived from a variety of
solid-phase syntheses alongside natural products and
bioactive compounds, such as FDA-approved drugs.
These arrays contain greater chemical diversity and
therefore are more desirable for ligand discovery. Addi-
tionally, first screening the diversity array helps re-
searchers select libraries for further, focused screening.
Future diversity arrays will take advantage of computa-
tional methods and molecular descriptor analysis to
guide decisions about which compounds to include in
an effort to maximize chemical diversity.
In an effort to verify the printing of complex collections
of small molecules with variable functional groups, we
probed a diverse SMM with a series of antibodies with
known specificities for bioactive small molecules. Struc-tural analogs of the known target of these antibodies
were also identified, indicating that large, diverse collec-
tions of printed molecules may yield insights into struc-
ture binding properties of immunoglobulins. This ap-
proach has implications for immunoglobulin profiling
as has been reported previously with focused carbohy-
drate arrays [37]. Importantly, profiling antibody speci-
ficity among large, diverse libraries of small molecules
as presented herein offers unique opportunities for
rapid diagnostic, therapeutic, and neutralizing antibody
discovery.
SMMs resulting from isocyanate-mediated capture
are also compatible with binding screens involving total
cell lysates containing endogenous or overexpressed,
epitope-tagged proteins. The ability to screen directly
from lysates saves substantial time and effort by avoid-
ing protein purification, and offers the possibility of
ligand discovery for proteins which have eluded com-
prehensive approaches at purification. Lysate screens
are more biologically relevant, as many proteins of inter-
est reside within protein complexes or require a protein
partner to remain active. Proteins obtained from cellular
lysates are also more likely to fold properly and possess
posttranslational modifications associated with an
active or desirable tertiary structure. The proteins from
lysates may also serve to block the surface, thereby creat-
ing a competitive assay. The linkage of the small molecule
to the surface prepared by using isocyanate capture also
appears to be stable to cellular esterases and proteases
under lysate screening conditions, as the slides can be
stripped under denaturing conditions and reprobed
Small-Molecule Microarrays and Cellular Lysates
501Figure 7. Analysis of Small-Molecule Micro-
arrays Screened with Cellular Lysates
(A) An array of 10,800 features was printed
with a diverse set of known bioactives, natu-
ral products, AP1497 derivatives, and com-
pounds prepared through diversity-oriented
synthesis. DMF solvent (n = 158) was in-
cluded for printing to determine hit thres-
hold intensity. Five experiments with Flag-
FKBP12-overexpressing cellular lysates
were compared to five incubations with con-
trol, mock-transfected lysates. Each array
was subsequently incubated with an anti-
Flag monoclonal antibody and a secondary
Cy5-labeled anti-mouse antibody. An FKBP12-
probed array scanned for fluorescence at
532 nm (green) and 635 nm (red) is shown,
as well as a highlighted region demonstrating
binding to AP1497 derivatives.
(B) Identification of FKBP12 binders. SNR635
profiles for five Flag-FKBP12 and five control
arrays are shown. Each column is a sample
on a discrete array (C, control; FK, Flag-
FKBP12), and each row is a printed small mol-
ecule. The color scale indicates mean (0) and
maximum (2.24) SNR635 for DMF solvent
spots. Printed molecules with SNR635 above
the threshold established by printed solvent
and satisfying a level of significance (p %
0.05) by Fisher’s exact test are presented.
Complete data for each array are presented
in Supplemental Data.(data not shown). Signal-to-noise ratios in lysate ex-
periments with isocyanate capture are improved over
surfaces we have prepared that involve linkage to the
surface through an ester bond. Consequently, we
believe this new capability constitutes a major advance
in the SMM method and should expand its use as
a method to discover small-molecule partners for pro-
teins of interest. The diversity of printed features and the
compatibility of the SMM surface with this lysate screen-
ing protocol also allow profiling of complex mixtures of
proteins derived from cellular lysates without prior puri-
fication. An important caveat of all applications of SMMs
is the importance of antibody selection and quality.
Optimization is required of all antibodies employed,
especially as concerns the detection of binding events
with endogenous proteins. A detailed study of lysate
applications on SMMs is underway in our laboratories.
More than 1000 replicate diversity SMMs have been
printed to date. Through collaborations involving sev-
eral laboratories, more than 50 proteins, including single
purified proteins, purified protein complexes, and pro-
teins from clarified cell lysates, have been screened
against these microarrays. Of more than 100 interac-
tions tested, 86% retest as binders with estimated dis-
sociation constants of 0.5–20 mM in a secondary surface
plasmon resonance-based assay that involves immobi-
lization of the target protein on a dextran-coated sensor
surface and injection of the compound at varying con-
centrations [2]. Compounds that do not retest are typi-
cally classified as insoluble, nonspecific binders to dex-
tran, or false positives.In summary, we have developed a new method for
preparing small-molecule microarrays that can be ap-
plied to compounds containing a range of nucleophilic
functional groups, thereby increasing both the diversity
and quantity of compounds, from natural or synthetic
sources, that can be immobilized for microarray-based
binding screens. We were able to detect and confirm
the presence of selected printed small molecules, and
structurally related compounds, with antibodies. Finally,
we used this chemistry to prepare diversity SMMs con-
taining nearly 10,000 small molecules and used the mi-
croarrays to demonstrate that the surface is compatible
with detection of interactions using total protein from
cellular lysates without any purification. Future efforts
will make use of antibodies and the lysate-compatible
diversity SMMs for profiling binding selectivity and
changes in cell state by using small-molecule binding
as a signature. We also aim to enable import of data de-
rived from SMM experiments into the public database
ChemBank.
Significance
In this manuscript, we present a new method for the
preparation and screening of small-molecule microar-
rays. For the first time, we demonstrate the covalent
capture of natural products and synthetic bioactives
in significant numbers on functionalized glass micro-
arrays. This method increases substantially the diver-
sity, quantity, and three-dimensional display of
printed small molecules. Additionally, we present
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ecule microarrays with cellular lysates from human
cells. This technique enables the identification of li-
gands for proteins inaccessible by routine biochemi-
cal purification, greatly streamlines protein prepara-
tion, and allows screening of proteins which may
require synthesis in mammalian cell lines for proper
folding, complex formation, or posttranslational mod-
ification. These approaches will catalyze the efficient
and widespread screening of small-molecule microar-
rays with proteins of interest and increase access to
this technology. Additionally, they establish methods
for further exploration in profiling cell states, tissues,
and antibody specificity.
Experimental Procedures
Materials
Bioactive small molecules and natural products were purchased
from commercial sources. DOS molecules were obtained from the
Broad Chemical Biology Program. Compound 3s was the gift of
Dr. John Tallarico. Compounds 27 and 28 were obtained from Tim-
othy Clackson of Ariad Pharmaceuticals. The Flag-FKBP12 mam-
malian expression construct was the gift of Dr. Paul Clemons. The
EGFP-FKBP12 mammalian expression vector was constructed by
using the Creator cloning system purchased from Clontech Labora-
tories and an FKBP12 library vector was obtained from the Harvard
Institute of Proteomics. Antibodies against corticosterone, estra-
diol, and digitoxin were purchased from Sigma. Mouse anti-Flag
monoclonal antibody was purchased from Sigma. Goat anti-
FKBP12 polyclonal antibodies were purchased from Santa Cruz Bio-
technology. Alexa Fluor 647 goat anti-rabbit and Alexa Fluor 647
donkey anti-goat antibodies were purchased from Invitrogen. Cy5-
labeled goat anti-GST and rabbit anti-mouse antibodies were pur-
chased from Amersham Biosciences. Slides were scanned either
by using an Axon 4000B scanner at 5 mm resolution with 635 nm
and 532 nm lasers or by using an Axon 4200A scanner at 5 mm res-
olution with 488 nm and 532 nm lasers. Arrays were analyzed with
GenePix Pro 6.0 software purchased from Molecular Devices.
General Protocol for Preparation of Isocyanate Slides
Amino-functionalized glass slides, either prepared as described
previously [10] or commercially available g-aminopropylsilane
(GAPS) slides (Corning), were incubated in a solution of Fmoc-8-
amino-3,6-dioxaoctanoic acid (10 mM; Neosystem), PyBOP (10
mM), and iPr2NEt (20 mM) in DMF for at least 4 hr. The slides were
washed in DMF to remove excess coupling solution and incubated
in a solution of 10% (v/v) piperidine in DMF for 30 min (room temper-
ature) to remove the Fmoc group from the surface. Following a rinse
in DMF, the slides were activated in a solution of 10% (v/v) 1,6-diiso-
cyanatohexane (Aldrich) in DMF for 30 min at room temperature.
Three brief rinses in THF allow for complete removal of the activating
solution and fast drying of the slides before placement on the robotic
microarrayer platform. Depending on the length of the printing pro-
cess, printed slides were allowed to dry for at least 10 min (print runs
of > 2 hr) and up to 2 hr (short print runs) before they were placed
onto metal racks in a glass vacuum desiccator. A three-way adaptor
was attached to the desiccator, with tubing leading to a vacuum line
and a round bottom flask containing approximately 1 ml of pyridine.
Once the desiccator and flask were fully evacuated, the vacuum line
was shut off and the catalytic pyridine vapor normalized the pres-
sure for at least 4 hr. The slides were then immersed in a solution
of ethylene glycol (1 M in DMF) and 1% (v/v) pyridine for 10 min to
quench the surface. The slides were washed twice in DMF for 30
min, washed once in ethanol for 30 min, dried by centrifugation,
and stored at –20ºC prior to screening. Slides were stored up to 6
months under these conditions.
Preparation of Diversity Small-Molecule Microarrays
Small molecules from the diversity set were arrayed onto isocya-
nate-functionalized glass slides by using an OmniGrid100 Microar-
rayer (Genomic Solutions) outfitted with an ArrayIt Stealth 48-pin
print head and SMP3 spotting pins (TeleChem International) as de-scribed previously [2]. The microarrays contain 10,800 printed fea-
tures with 48 subarrays of 15 3 15 features with 320 mm center-to-
center spacing. Solutions of small molecules (w1 mM in DMF)
were printed from 384-well polypropylene plates (Abgene).
Twenty-eight plates containing 9152 DOS compounds [18–24], 336
bioactives, 72 control compounds, and 1192 blank wells containing
DMF were printed. Forty-eight wells of a 29th plate, containing var-
ious concentrations of rhodamine derivatives (w1 mM, DMF) [10],
were printed in the final dip to serve as fluorescent markers on the
array that frame the subarrays. Each pin was washed three times
for 5 s in acetonitrile and vacuum dried for 3 s between picking up
samples from the wells in an effort to minimize carryover contamina-
tion of samples. One hundred arrays were printed in a given print run
and more than 1000 copies of the diversity microarray have been
printed to date. Quality control for each print run involved scanning
arrays prior to screening and looking for the presence or absence of
various fluor control features as well as screens to detect selected
known protein-ligand interactions.
Microarray Screens with Purified FKBP12-GST
Microarrays were incubated with 300 ml of a 1 mg/ml solution of pu-
rified FKBP12-GST [30, 31] in PBST buffer (PBS [pH 7.4], 0.1%
Tween-20) for 30 min at room temperature. The arrays were briefly
rinsed with PBST and then washed twice in PBST (1 min for each
wash) on an orbital platform shaker. Arrays were then incubated
with 300 ml of a 0.5 mg/ml solution of Cy5-labeled goat anti-GST an-
tibody in PBST for 30 min at room temperature. Probed arrays were
rinsed in PBST, washed three times in PBST (2 min for each wash),
and washed once in PBS (2 min). Arrays were dried by centrifugation
and scanned for fluorescence at 635 nm on a GenePix 4000B micro-
array scanner. Control arrays were probed with either GST followed
by labeled antibody or labeled antibody alone to ensure that fluores-
cent signals were due to binding of FKBP12 to the printed ligands.
To analyze the array features containing ligands 3a–3q (Figure 3B),
total fluorescence intensity values were calculated for a set 300
mm diameter centered over each feature with GenePix Pro 6.0 soft-
ware. Intensities for each ligand at varying concentrations are dis-
played in a graph (Figure 3C).
Small-Molecule Microarray Profiles with Antibodies against
Natural Products
Microarrays printed with natural products and bioactives were incu-
bated with various antibodies to detect specific compounds. In the
first incubation step, arrays were incubated with 300 ml of one of the
following: PBST buffer (control), a 1:500 solution of rabbit anti-corti-
costerone whole antiserum in PBST, or 1:500 solution of rabbit anti-
17b-estradiol whole antiserum in PBST for 30 min at room tempera-
ture. The arrays were briefly rinsed with PBST and then washed
twice in PBST. All arrays were then incubated with 300 ml of
a 1:1000 solution of Alexa Fluor 647 goat anti-rabbit polyclonal sec-
ondary antibody in PBST for 30 min at room temperature. Probed ar-
rays were rinsed in PBST, washed three times in PBST, and washed
once in PBS. Arrays were dried by centrifugation and scanned for
fluorescence at 635 nm. SNR was calculated for each feature with
adjusted diameters.
Microarray Screens with FKBP12 from Lysates
Routine culture of HEK-293T cells was performed in DMEM supple-
mented with penicillin/streptomycin and 10% fetal bovine serum.
Transfection of HEK-293T cells with mammalian overexpression
vectors was performed by FuGENE6 lipid transfection (Roche Ap-
plied Science). Cells were harvested after 48 hr, and clarified lysates
were prepared by incubation with MIPP lysis buffer (20 mM NaH2PO4
[pH 7.2], 1 mM Na3VO4, 5 mM NaF, 25 mM b-glycerophosphate, 2
mM EGTA, 2 mM EDTA, 1 mM DTT, 0.5% [v/v] Triton X-100) and cen-
trifugation. Additional lysis buffer was added to a total protein con-
centration of 0.3 mg/ml, and overexpression of the target protein
was verified by Western blot (data not shown). Small-molecule mi-
croarrays were serially incubated with clarified lysates, primary an-
tibody, and an appropriate fluorophore-coupled secondary anti-
body. Unless otherwise specified, antibodies were diluted to 0.5
mg/ml in PBST supplemented with 1.0% bovine serum albumin. All
incubations were performed for 1 hr at 4ºC. Slides were briefly
washed with PBST following incubations. After a brief rinse in dis-
tilled water, slides were dried by centrifugation, scanned, and ana-
lyzed as described above. SMMs probed with lysates overexpress-
ing EGFP-FKBP12 were incubated for 1 hr, washed briefly with
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as described above. SMMs incubated with untransfected lysates for
the detection of small-molecule interactions with endogenous
FKBP12 were prepared and analyzed as above; however, the pri-
mary antibody was incubated at a concentration of 20 mg/ml in
PBST supplemented with 1.0% bovine serum albumin.
Statistical Methods
Ten microarrays (five treatment and five control) were used to deter-
mine interactions of printed small molecules with FKBP12-contain-
ing cell lysates. Each of the microarrays contained a total of
10,800 printed features. Of the 10,800 features on each microarray,
158 features contained only solvent and were used as negative con-
trols to establish a threshold for intensity. The maximum fluo-
rescence intensity value (i.e., threshold) over all the solvent cells
(158 3 10 = 1580) was found to be 2.24. Using this threshold value
to dichotomize the data, a Fisher’s exact test was used to evaluate
the hypothesis that the treatment cells had greater intensities than
those of the control features. Contingency tables and p values
were generated for 104 solvent-only features in which at least one
cell demonstrated fluorescence intensity above the threshold. Cal-
culations were performed with the exact option in SAS (Cary, NC),
and no p value adjustment was made for multiple comparisons.
Supplemental Data
Supplemental Data contain a list of bioactive compounds obtained
from commercial sources, spreadsheets of fluorescence intensity
data for microarray screens in Figures 4, 5B, and 7, detailed informa-
tion about the synthesis and analysis of ligands 3a–3r, and SPR
binding curves for 1276-M08, and are available at http://www.
chembiol.com/cgi/content/full/13/5/493/DC1/. Also included is a de-
tailed protocol for screening SMMs using cellular lysates.
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